Recent Articles from GlobeNewswire

NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against New Era Energy & Digital, Inc. (“New Era” or the “Company”) (NASDAQ: NUAI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

LONG BEACH, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carbon TerraVault Holdings, LLC (CTV), a carbon management subsidiary of California Resources Corporation (NYSE: CRC), today provided a first quarter 2026 update on its financial and operating results.

GREENWICH, Conn., May 05, 2026 (GLOBE NEWSWIRE) -- GXO Logistics, Inc. (NYSE: GXO) today announced results for the first quarter 2026.

TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (TSX: CG) (NYSE: CGAU) (“Centerra” or the “Company”) announces the results of its 2026 Annual Meeting of Shareholders (the “Meeting”) held on May 5, 2026. A total of 152,456,607 shares, representing 76.39% of common shares issued and outstanding, were represented at the Meeting. Detailed voting results are outlined below.

Second Quarter 2026 Diluted earnings per share (“EPS”) of $1.27 and Adjusted EPS of $1.61

DUBLIN, IRELAND, May 05, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly dividend of $0.63 per share. The dividend is payable on June 26, 2026, to shareholders of record at the close of business on June 8, 2026.  

NEW YORK, May 05, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR) and certain officers.   The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-01951, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Nektar securities between February 26, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. 

White Oak, Md., May 05, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) today authorized the marketing of four Glas electronic nicotine delivery systems (ENDS) through the premarket tobacco product application (PMTA) pathway. Each product is an e-liquid pod containing 50mg/ml (or 5%) of tobacco-derived nicotine. The authorized pods include Classic Menthol, Fresh Menthol, Gold, and Sapphire. This action marks the FDA’s first authorization of non-tobacco and non-menthol ENDS products.

MONDOVI, Wis., May 05, 2026 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.06 per share of common stock. The dividend will be payable on June 30, 2026 to stockholders of record at the close of business on June 16, 2026.

Details Success of Pacira’s 5x30 Strategy and Solid First Quarter 2026 Results 

GAAP Net Income of $168 million, or $1.18 per diluted shareAdjusted Operating Income of $172 million, or $1.21 per diluted shareReturn on Equity of 12.5% and Adjusted Operating Return on Equity of 12.9%Primary Insurance in-force of $272 billion, a 2% year-over-year increasePMIERs Sufficiency of 162% or approximately $1.9 billionBook Value Per Share of $38.09 and Book Value Per Share excluding AOCI of $38.68

trivago N.V. files Antitrust Damages Claim Against Google in Germany

SANTA CLARA, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- AMD (NASDAQ:AMD) today announced financial results for the first quarter of 2026. First quarter revenue was $10.3 billion, gross margin was 53%, operating income was $1.5 billion, net income was $1.4 billion and diluted earnings per share was $0.84. On a non-GAAP(*) basis, gross margin was 55%, operating income was $2.5 billion, net income was $2.3 billion and diluted earnings per share was $1.37.

FRISCO, TX, May 05, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. ("Comstock" or the "Company") (NYSE; NYSE Texas: CRK) today reported financial and operating results for the quarter ended March 31, 2026.

HAMILTON, BERMUDA, May 5, 2026 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended March 31, 2026.

Dallas, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- CompX International Inc. (NYSE American: CIX) announced today net sales of $40.6 million for the first quarter of 2026 compared to $40.3 million in the same period of 2025. Operating income was $7.1 million in the first quarter of 2026 compared to $5.9 million in the same period of 2025. Net income was $5.9 million, or $.48 per basic and diluted common share, for the first quarter of 2026 compared to $5.1 million, or $.42 per basic and diluted common share, in the same period of 2025.

HOUSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced its first quarter 2026 financial results. The earnings release and accompanying financial schedules can be accessed via the Investor Relations section of the company’s website at oxy.com. The earnings release is also available on the U.S. Securities and Exchange Commission’s website at sec.gov.

LAS VEGAS, NV, May 05, 2026 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $5.5 million, or $0.24 per diluted share for its first quarter ended March 31, 2026. This represents an 18% increase in net income compared to $4.7 million in the first quarter of 2025. Earnings per diluted share increased by 26% compared to $0.19 in the first quarter of 2025.

SANTA MONICA, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Super League (Nasdaq: SLE) (the “Company”), an audience intelligence and media activation company trusted by global brands to reach and influence people who play video games across the digital landscape, announced today that the Company will post its first quarter 2026 financial results before market open on Friday, May 15, 2026. A webinar will be held the same day at 8:30 am Eastern Time to discuss the results and can be accessed using the below dial-in numbers or registration link.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- Angi Inc. (NASDAQ: ANGI) posted its first-quarter financial results and a letter to shareholders from CEO Jeffrey Kip on the investor relations section of its website at ir.angi.com/quarterly-earnings. As announced previously, Angi Inc. will host a conference call to discuss the company’s first-quarter results and answer questions. The call will be held on Wednesday, May 6, 2026, at 8:30 a.m. ET. Jeffrey Kip, CEO, and Julie Hoarau, CFO, will participate.

Exceeded estimates for revenue and non-GAAP operating incomeLanded the two largest deals in company's history, including first $1 million-plus ARR deal

RALEIGH, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced that its Board of Directors declared a quarterly dividend of $0.24 per common share, an increase of 14% from the prior quarter’s dividend. This dividend will be payable on June 18, 2026 to shareholders of record on May 28, 2026.

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

PRESS RELEASE

Phase 2 Data Highlight the Observed Abscopal-like Effect of VP-315 in Non-treated Basal Cell Carcinoma Tumors 

First Quarter Revenue Increased 41.0% Year-over-Year

Earnings Release Highlights

Highlights

ROCKVILLE, Md., May 05, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced financial results for the first quarter 2026 and associated Company developments.

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Rapid7, Inc. (Nasdaq: RPD), a global leader in AI-powered managed cybersecurity operations, today announced its financial results for the first quarter 2026.

DENVER, May 05, 2026 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE), today announced financial results for its fiscal third quarter ended March 31, 2026.

Over 3 million Paid Subscribers, up 3% over Q1 2025  

Board Approves Joint Venture with Magnetar to Form Neostellar Advisors LLC

Now Shipping to Leading Hyperscalers, Scorpio Smart Fabric Switch Family Delivers Breakthrough Accelerator Utilization Through Memory-Semantic Based Open and Platform-Specific Protocols

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results for the quarter ended March 31, 2026.

LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- BlackLine, Inc. (Nasdaq: BL), today announced financial results for the first quarter ended March 31, 2026.

BERKELEY, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at BofA Securities 2026 Health Care Conference on May 13, 2026, at 8:40am PT in Las Vegas, Nevada.

FDA Breakthrough Therapy designation granted to zovegalisib for PIK3CA-mutant, HR+/HER2- advanced breast cancer, the Phase 3 ReDiscover-2 trial population in 2L breast cancer

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today announced financial results for the first quarter ended March 31, 2026. The company’s first quarter earnings report can be viewed at investors.amwell.com.

SAN JOSE, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a leader in semiconductor-based connectivity solutions for rack-scale AI infrastructure, today announced preliminary financial results for the first quarter of fiscal year of 2026, ended March 31, 2026.

First Quarter 2026 Financial Highlights:

LOS ANGELES, May 05, 2026 (GLOBE NEWSWIRE) -- ServiceTitan, Inc. (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will report its financial results for the fiscal first quarter ended April 30, 2026 after market close on Thursday, June 4, 2026. In conjunction with this report, ServiceTitan will host a conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on the same day to discuss its fiscal first quarter financial results, as well as fiscal year 2027 outlook.

MOUNTAIN VIEW, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the first quarter 2026 and provide a business update after the close of trading on May 19, 2026.

FREMONT, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will be participating in the upcoming BofA Securities 2026 Healthcare Conference in Las Vegas, Nevada.

SEATTLE, May 05, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentation at the BofA Securities 2026 Healthcare Conference at 2:20 p.m. PT on Tuesday, May 12, 2026. The presentation will feature a business overview and update by Steve Harr, Sana’s President and Chief Executive Officer.

CEDARHURST, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- Postal Realty Trust, Inc. (NYSE: PSTL) (the “Company”), an internally managed real estate investment trust that owns and manages over 2,300 properties leased primarily to the United States Postal Service (the “USPS”), ranging from last-mile post offices to industrial facilities, announced today that its board of directors has approved a quarterly dividend on the Company’s Class A common stock in the amount of $0.245 per share. This represents a 1.0% increase from the first quarter 2025 dividend. The dividend will be payable on May 29, 2026 to stockholders of record as of the close of business on May 15, 2026.

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ: AVTX) (“Avalo”), a clinical-stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. All of the shares of common stock and pre-funded warrants to be sold in this offering are being offered by Avalo. In addition, Avalo intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of shares of its common stock (and shares of common stock underlying pre-funded warrants) offered in the public offering on the same terms and conditions. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

High-volume orders from multiple customers for its Spector®, Lumina® and Wet Processing Systems to drive strong growth.

Southfield, Michigan, May 05, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) today announced consolidated net income of $135.8 million, or $12.40 per diluted share, for the three months ended March 31, 2026. Adjusted net income, a non-GAAP financial measure, for the three months ended March 31, 2026 was $117.3 million, or $10.71 per diluted share. The following table summarizes our financial results:

First Quarter 2026 Highlights:

ROLLING MEADOWS, Ill., May 05, 2026 (GLOBE NEWSWIRE) -- RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and Dogwalkers, today announced financial results for the first quarter ended March 31, 2026.

First quarter 2026 revenue of $16.1 million, representing 58% growth year-over-year

IRVINE, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Skyworks Solutions, Inc. (Nasdaq: SWKS), a leading developer, manufacturer and provider of analog and mixed-signal semiconductors and solutions for numerous applications, today reported second fiscal quarter results for the period ended April 3, 2026.

WAYNE, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β based treatments for immune-mediated inflammatory diseases, today announced positive topline results from its Phase 2 LOTUS trial evaluating the efficacy and safety of abdakibart in adults with moderate to severe hidradenitis suppurativa (HS). The LOTUS trial successfully met its primary endpoint at both doses studied. Based on these data, Avalo plans to advance abdakibart into a registrational phase 3 program.

First quarter net income of $1.15 per diluted share and adjusted operating income of $1.16 per diluted share

Net Increase in Net Assets from Operations of $0.31 Per Share; Net Asset Value of $18.16 Per Share

First quarter total revenue of $136 million, Crysvita® revenue of $93 million and Dojolvi® revenue of $18 million

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on May 1, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 5,420 shares of its common stock to twenty-one new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock or, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its common stock, in a proposed underwritten public offering. All of the shares of common stock and pre-funded warrants to be sold in the proposed offering are being offered by Hyperion DeFi. In addition, Hyperion DeFi intends to grant the sole underwriter a 30-day option to purchase up to an additional 15% of the total number of securities offered in the public offering. There can be no assurance as to whether or when the proposed public offering may be completed, or as to the actual size or terms of the proposed offering.

Early GO decision reached in CAPTIVATE in March 2026 based on GO criteria of 20 confirmed responders achieved with less than 40 planned participants completing open-label Part A 

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of inducement equity awards to four newly hired non-executive employees as a material inducement to commencing their employment with the Company.

BOSTON, May 05, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced two presentations at the American Thoracic Society (ATS) 2026 International Conference being held May 15-20, 2026, in Orlando, FL.

Southfield, Michigan, May 05, 2026 (GLOBE NEWSWIRE) -- Credit Acceptance Corporation (Nasdaq: CACC) (referred to as the “Company”, “Credit Acceptance”, “we”, “our”, or “us”) announced today the completion of a $450.0 million asset-backed non-recourse secured financing (the “Financing”).  Pursuant to this transaction, we conveyed loans having a value of approximately $562.6 million to a wholly owned special purpose entity which will transfer the loans to a trust, which will issue three classes of notes:

LONDON, UK and BOCA RATON, FL, May 05, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (“INmune Bio”), a clinical-stage biotechnology company, and Anthony Nolan, a pioneering UK-based charity that set up the world's first stem cell register and is now driving forward cell therapy advancements, today announced the signing of an amended and restated Material Transfer and License Agreement. This expanded collaboration secures the long-term provision of high-quality umbilical cord tissue to power INmune Bio’s CORDStrom™ platform, the industry’s most advanced Mesenchymal Stromal Cell (MSC) technology designed to deliver consistent, scalable, and "off-the-shelf" cellular therapies which are suitable for supply in UK, EU and US, as well as other global regions.

MARYSVILLE, Ohio, May 05, 2026 (GLOBE NEWSWIRE) -- To promote active engagement with green spaces during childhood, The Scotts Miracle-Gro Foundation and KidsGardening have named 120 community organizations as recipients of the 2026 GroMoreGood Grassroots Grant. This annual initiative provides funding to support local programs to establish or expand youth-focused gardens and outdoor play spaces.

NEWTON, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, today announced that the Company will report first quarter financial results on Tuesday, May 12, 2026. The Company will host a conference call and live audio webcast at 8:00 a.m. ET to provide a business and financial update.  

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. 

DOVER, USA, May 05, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, today announced that its majority-owned subsidiary has officially onboarded a veteran technical team specializing in high-performance AI power supply units (PSU). Since late 2024, this team has been in deep technical collaboration with NVIDIA, providing cutting-edge solutions for ultra-high power density, liquid cooling, and power smoothing architectures.

Boulder, CO, May 05, 2026 (GLOBE NEWSWIRE) -- Kitchens Elevated, a boutique kitchen design and cabinetry studio based in Boulder, announces the expansion of its sustainability initiatives with a unique foam recycling program aimed at tackling one of the industry’s most overlooked environmental challenges: styrofoam packaging waste. Known for blending high-end design with functionality, Kitchens Elevated is now taking its commitment further by ensuring that even the hidden byproducts of luxury remodeling are handled responsibly.

BEDFORD, Texas, May 05, 2026 (GLOBE NEWSWIRE) -- Legacy Housing Corporation ("Legacy" or the "Company", NASDAQ: LEGH) will release its financial results for the first quarter ended March 31, 2026, after markets close on Thursday, May 7, 2026. The Company will then host a conference call at 12:00 p.m. Central Time on Friday, May 8, 2026.

Continued Positive Performance and Strong Student Starts Growth Reflects Demand for Skilled Labor Across the Company’s Campuses

Gosselies, Belgium, May 05, 2026 (GLOBE NEWSWIRE) --

BOCA RATON, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) (“NewtekOne”) today announced its selection to participate in the inaugural Emerging Company Pavilion at the 2026 Sohn New York Investment Conference, taking place May 12 at Jazz at Lincoln Center in New York City.